Is the Medtronic (Medtronic) Micra leadless pacemaker (implantable cardiac pacemaker) affected by Magnetic Resonance Imaging (MRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRI Compatibility of the Medtronic Micra Leadless Pacemaker

The Medtronic Micra leadless pacemaker is MRI-conditional and can safely undergo MRI scanning at both 1.5T and 3.0T when manufacturer instructions are followed. 1

Why Leadless Pacemakers Are Inherently Safer for MRI

The Micra system carries substantially lower MRI-related risks compared to traditional transvenous pacemakers due to its unique design characteristics:

  • No transvenous leads eliminates the primary risk of radiofrequency-induced heating at lead tips, which is the most dangerous complication with conventional pacemakers 1
  • Smaller device size results in minimal electromagnetic interactions, with modeling studies demonstrating temperature rises of less than 0.4°C at 1.5T and 0.5°C at 3T 2
  • No pulse generator pocket removes concerns about device-tissue interface heating 1
  • Absence of lead system eliminates risks of pacing inhibition, inappropriate sensing, and lead-related arrhythmia induction that plague conventional systems 1

Pre-MRI Safety Requirements

Before proceeding with MRI, verify these mandatory criteria:

  • Confirm MRI-conditional status directly with Medtronic's device specifications for the specific Micra model implanted 3, 1
  • Wait minimum 6 weeks post-implantation to ensure device position stabilization, though leadless pacemakers have no risk of lead dislodgement 3, 1
  • Perform device interrogation to record baseline parameters including impedance, capture threshold, sensing amplitude, and battery voltage 3, 1
  • Program according to manufacturer specifications, which typically involves automatic mode switching via external activation 3

Field Strength Considerations

The Micra system demonstrates excellent safety profiles at both standard field strengths:

  • 1.5T scanning is the preferred and most extensively validated field strength, producing less intense artifacts 4
  • 3.0T scanning is also safe and feasible, though it generates more prominent artifacts in the right ventricle and septal region 4, 5
  • Clinical studies show no statistically significant differences in device parameter changes between 1.5T and 3.0T scanning (pacing threshold changes: 0.01 ± 0.05V at 1 month, P=0.308) 5

Imaging Artifact Considerations

While the device is safe for MRI, be aware of imaging limitations:

  • A characteristic shamrock-shaped artifact appears around the device, affecting visualization of the right ventricle and interventricular septum 4
  • The artifact is more intense at 3T compared to 1.5T in both magnitude and brightness 4
  • The majority of myocardium remains artifact-free and evaluable for detecting ischemia, inflammatory processes, and other cardiac pathology 4
  • Use 1.5T as the preferred field strength when image quality in the septal region is critical 4

Intra-Procedure Monitoring

During the MRI scan, maintain these safety protocols:

  • Continuous ECG monitoring throughout the entire procedure by qualified personnel 3
  • Follow manufacturer's programming instructions, which typically involve automatic mode switching 3
  • For pacemaker-dependent patients, program to asynchronous mode (VOO/DOO) to prevent inappropriate inhibition 3
  • For non-pacemaker-dependent patients, use inhibited mode (VVI/DDI) to avoid inappropriate pacing 3

Post-MRI Device Assessment

Immediately after MRI completion:

  • Re-interrogate the device and compare all parameters to baseline measurements 3
  • Restore original programming settings 3
  • Clinical studies demonstrate stable device parameters with no significant changes at 1-month and 3-month follow-up (impedance change: -7.86 ± 30.7 Ohm, P=0.447) 5

Critical Advantages Over Conventional Pacemakers

The contrast with traditional pacemaker systems is stark:

  • Conventional pacemakers carry Class IIb recommendations (less favorable benefit-risk ratio) for MRI and require mandatory electrophysiology consultation 6, 7
  • Older guidelines from 2005 stated MRI was generally contraindicated for all cardiac rhythm management devices 6
  • The Micra system eliminates most historical contraindications due to its leadless design 1

Multiple Device Implants

If a patient has multiple Micra devices implanted:

  • No increased heating risk with multiple devices compared to single device implantation 2
  • Monte Carlo simulations confirm safety across various body positions and coil designs 2

Common Pitfall to Avoid

Never assume MRI compatibility based on the device being "leadless" alone—always verify the specific Micra model number is MRI-conditional, as not all leadless pacemaker systems may have identical MRI specifications 3, 1.

References

Guideline

MRI Compatibility of Leadless Pacemakers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MRI Compatibility of Pacemakers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Monocenter Investigation Micra® MRI study (MIMICRY): feasibility study of the magnetic resonance imaging compatibility of a leadless pacemaker system.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

MRI Contraindications in Patients with Implants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.